201 related articles for article (PubMed ID: 22236140)
1. Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.
Hafeman SD; Varland D; Dow SW
Vet Comp Oncol; 2012 Mar; 10(1):44-56. PubMed ID: 22236140
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs.
Hafeman S; London C; Elmslie R; Dow S
Cancer Immunol Immunother; 2010 Mar; 59(3):441-52. PubMed ID: 19760220
[TBL] [Abstract][Full Text] [Related]
3. A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.
Takada M; Parys M; Gregory-Bryson E; Vilar Saavedra P; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2018 Mar; 18(1):237. PubMed ID: 29490634
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
Cannon C; Borgatti A; Henson M; Husbands B
J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
[TBL] [Abstract][Full Text] [Related]
6. [New approach to the treatment of primary malignant non-Hodgkin's lymphoma of the stomach].
Korobko VB; Chernyĭ VA; Valetskiĭ VL; Rozumiĭ DA; Gunina LM
Klin Khir; 1996; (1):39-42. PubMed ID: 8768208
[No Abstract] [Full Text] [Related]
7. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and Doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction.
Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
J Vet Intern Med; 2011; 25(2):285-91. PubMed ID: 21314729
[TBL] [Abstract][Full Text] [Related]
9. Malignant histiocytosis with multiple skin lesions in a dog.
Uno Y; Momoi Y; Watari T; Goitsuka R; Tsujimoto H; Shimada T; Ono K; Goto N; Hasegawa A
J Vet Med Sci; 1993 Dec; 55(6):1059-61. PubMed ID: 8117808
[TBL] [Abstract][Full Text] [Related]
10. [Malignant histiocytosis. Clinical contribution and review of the subject].
Montalbetti L; Berini M; Nerviani M; Brambilla Pisoni G
Minerva Med; 1987 Mar; 78(5):333-8. PubMed ID: 3822226
[TBL] [Abstract][Full Text] [Related]
11. [Malignant histiocytosis. Remission for more than 5 years].
Lejeunne C; Degos L; Pol S; Hugues FC
Presse Med; 1990 Feb; 19(5):218. PubMed ID: 2137919
[No Abstract] [Full Text] [Related]
12. Doxorubicin and zoledronate treatment in a dog with hemophagocytic histiocytic sarcoma.
Soileau AM; Neto RLALT; Jimenez PT; Hamersky J; Smith AA
Can Vet J; 2023 Dec; 64(12):1103-1108. PubMed ID: 38046421
[TBL] [Abstract][Full Text] [Related]
13. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
[TBL] [Abstract][Full Text] [Related]
14. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological diagnosis and treatment of malignant histiocytosis.
Sonneveld P; van Lom K; Kappers-Klunne M; Prins ME; Abels J
Br J Haematol; 1990 Aug; 75(4):511-6. PubMed ID: 2207002
[TBL] [Abstract][Full Text] [Related]
16. Ventricular fractional shortening in 108 dogs with malignant lymphoma undergoing chemotherapy with a cyclic combination protocol including doxorubicin.
Tater G; Eberle N; Hungerbuehler S; Joetzke A; Nolte I; Wess G; Betz D
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):261-6. PubMed ID: 22911257
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal and hematologic adverse events after administration of vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma that underwent a combination multidrug chemotherapy protocol.
Tomiyasu H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2010 Nov; 72(11):1391-7. PubMed ID: 20543531
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
19. [Malignant histiocytosis with complex chromosomal abnormality: successful treatment with CHOP-E chemotherapy].
Mori H; Shimizu T; Harada H; Miyoshi Y; Okada S; Takizawa Y; Niikura H; Terada H; Fujita K
Rinsho Ketsueki; 1991 Mar; 32(3):244-9. PubMed ID: 2041166
[TBL] [Abstract][Full Text] [Related]
20. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
Gray KN; Raulston GL; Gleiser CA; Jardine JH
J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
